Prinz Law

The California Biotech Law Blog reported that the outlook for biotech in 2012 was expected to remain dreary, and that companies would continue to focus on acquisitions over IPOs in the following blog post:

 http://californiabiotechlaw.com/archives/biotech-ipos/ipo-outlook-for-biotech-remains-dreary-in-2012/

The California Biotech Law Blog looked at the issue of how patent reform would affect the biotech industry in the following blog post link:

 http://californiabiotechlaw.com/archives/biotech-legislative-developments/the-passage-of-patent-reform-is-this-really-a-win-for-the-biotech-industry/

How is the biotech industry reacting to the passage of health care reform?  The California Biotech Law Blog explored the industry reaction in the following blog post:

http://californiabiotechlaw.com/archives/biotech-legislative-developments/biotech-industry-evaluates-anticipated-impact-of-health-care-reform/

The California Biotech Law Blog announced that the blog has been recognized as a top 50 biotech blog in the following blog post:

http://californiabiotechlaw.com/archives/biotech-blog-in-the-news/california-biotech-law-blog-named-to-list-of-top-50-biotech-blogs/

The California Biotech Law Blog explored the issues delaying SBIR reauthorization in the following blog post:

http://californiabiotechlaw.com/archives/biotech-legislative-developments/sbir-reauthorization-effort-continues-to-be-at-standstill/

The Silicon Valley IP Licensing Law Blog compared and contrasted the Leahy-Hatch and Kyl Patent Reform Bills in the follow blog post linked below:

http://www.siliconvalleyiplicensinglaw.com/congress-set-to-consider-leahy-hatch-kyl-patent-reform-bills/

Biotech and Life Sciences IP Licensing Lawyer Kristie Prinz speak on January 11, 2008 on the IP Panel for Process Management–Route to Success at PepTalk which will be held at Hotel Del Coronado, San Diego.

For more details about the event, please click here.